Monsenso A/S (CPH:MONSO)
Denmark · Delayed Price · Currency is DKK 0.1370
0.00 (0.00%)
Mar 25, 2026, 5:00 PM CET
Monsenso Market Cap
Monsenso has a market cap or net worth of 9.15 million as of March 26, 2026. Its market cap has decreased by -50.26% in one year.
Market Cap
9.15M
Enterprise Value
10.94M
Revenue
8.91M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.14
Market Cap Chart
Since June 10, 2020, Monsenso's market cap has decreased from 96.87M to 9.15M, a decrease of -90.56%. That is a compound annual growth rate of -33.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 25, 2026 | 9.15M | -8.67% |
| Dec 30, 2025 | 10.02M | -59.16% |
| Dec 30, 2024 | 24.52M | 177.63% |
| Dec 29, 2023 | 8.83M | -21.75% |
| Dec 30, 2022 | 11.29M | -59.30% |
| Dec 30, 2021 | 27.73M | -82.99% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.04T |
| Genmab | 101.63B |
| Coloplast | 94.73B |
| ALK-Abelló | 44.62B |
| BioPorto | 450.54M |
| Pharma Equity Group | 103.61M |
| ViroGates | 102.56M |
| Scandinavian Medical Solutions | 90.93M |